0:06:37

Transcend CLL 004 Update #ASH19 @cityofhope

Name: Transcend CLL 004 Update #ASH19 @cityofhope
Uploaded: 2019-12-20T09:53:36
Duration: 6 min 37 s
Description: Tanya Siddiqi, MD of @cityofhope discusses the updated results from transcend CLL 004, a Phase 1/2 study including patients with high-risk disease treated with ibrutinib.

ash

6 months

15 Views

Share Report Add to 0 0

Share Video (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://www.oncologytube.com/videoEmbed/38335/transcend-cll-004-update-ash19-cityofhope?channelName=ash" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Share Video (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://www.oncologytube.com/videoEmbed/38335/transcend-cll-004-update-ash19-cityofhope?channelName=ash"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://www.oncologytube.com/videoEmbed/38335/transcend-cll-004-update-ash19-cityofhope?channelName=ash" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Chronic Lymphocytic Leukemia

Description:

Tanya Siddiqi, MD of @cityofhope discusses the updated results from transcend CLL 004, a Phase 1/2 study including patients with high-risk disease treated with ibrutinib.